Global Health Innovation Network
The Global Health Innovation Network (GHIN) brings together partners from Sweden and Singapore, including Ericsson, AstraZeneca and Sahlgrenska University Hospital. The collaboration aims to develop and scale solutions to global health challenges.
GHIN focuses on identifying, implementing and scaling healthcare innovations in screening, diagnostics and monitoring. The goal is to facilitate the real-world adoption of innovative technologies, addressing one of the major challenges in healthcare systems worldwide.
Sahlgrenska University Hospital has established a strategic international partnership with the National University Health System (NUHS) in Singapore, together with industry partners AstraZeneca, Ericsson, and Business Sweden. The collaboration is excercised through the Global Health Innovation Network (GHIN), an initiative designed to advance healthcare innovation on a global scale.
The partnership brings together clinical expertise, research capabilities, and technological innovation to support the development, implementation, and scaling of new healthcare solutions. A key focus is on areas such as screening, diagnostics, and monitoring, where emerging technologies can improve both quality of care and system efficiency.
Within the collaboration, Sahlgrenska and NUHS contribute clinical insight, research collaboration, and test environments, while the industry partners provide technological and innovation expertise. Together, they create a platform for knowledge exchange, joint development, and real-world application of new solutions.
The partnership reflects a long-term commitment to international collaboration, with the shared ambition of accelerating innovation and ensuring that new treatments and technologies reach patients more quickly—both regionally and globally.